References
- Kawamata K, Neki R, Yamanaka K, et al. Risks and pregnancy outcome in women with Prosthetic mechanical heart valve replacement. Circ J. 2007;71:211–213.
- Tanaka H, Tanaka K, Kamiya C, et al. Analysis of anticoagulant therapy by unfractionated heparin during pregnancy after mechanical valve replacement. Circ J. 2014;78:878–881.
- D’Souza R, Ostro J, Shah PS, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J. 2017;38:1509–1516.
- Vause S, Clarke B, Tower CL, et al. Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system. BJOG: Int J Obstet Gy. 2017;124:1411–1419.
- van Hagen IM, Roos-Hesselink JW, Ruys TP, et al. Pregnancy in women with a mechanical heart valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation 2015;132:132–142.
- Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:2440–2492.
- European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–3197.
- Yurdakök M. Fetal and neonatal effects of anticoagulants used in pregnancy: a review. Turk J Pediatr. 2012;54:207–215.
- Fuller KP, Turner G, Polavarapu S, et al. Guidelines for use of anticoagulation in pregnancy. Clin Lab Med. 2013;33:343–356.
- Honda K, Okamura Y. Mechanical valves and anticoagulation in pregnancy. Circ J. 2014;78:825–826.
- Masamoto H, Uehara H, Mekaru K, et al. Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report. Am J Perinatol. 2009;26:597–600.
- Lee HC, Cho SY, Lee HJ, et al. Warfarin-associated fetal intracranial hemorrhage: a case report. J Korean Med Sci. 2003;18:764–767.
- Matsuda Y, Hashiguchi K, Akizawa Y, et al. A case of fetal subdural hematoma at 31 weeks of gestation in a woman on warfarin therapy after Cabrol’s operation. Fetal Diagn Ther. 2003;18:252–254.
- Takahashi H, Wilkinson GR, Nutescu EA, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics. 2006;16:101–110.